InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Fowler John Franklin. Officer active across 1 company, notably Kezar Life Sciences, Inc.. In total, 2 filings have been logged. History available since 14 December 2021. The latest transaction was disclosed on 10 November 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Fowler John Franklin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
27,000 股@ US$0.9066.4% 占其流量Common StockSEC:0001209191-22-056479:0
7,700 股@ US$0.9020.2% 占其流量Common StockSEC:0001209191-21-069814:0
2 条申报中的 2 条
